nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—thyroid cancer	0.479	1	CbGaD
Nateglinide—ORM1—Vandetanib—thyroid cancer	0.104	0.234	CbGbCtD
Nateglinide—UGT1A9—Sorafenib—thyroid cancer	0.0852	0.192	CbGbCtD
Nateglinide—ABCC4—Sorafenib—thyroid cancer	0.0713	0.16	CbGbCtD
Nateglinide—ALB—Vandetanib—thyroid cancer	0.0438	0.0986	CbGbCtD
Nateglinide—CYP3A7—Sorafenib—thyroid cancer	0.0283	0.0637	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0283	0.0637	CbGbCtD
Nateglinide—CYP3A5—Sorafenib—thyroid cancer	0.0212	0.0478	CbGbCtD
Nateglinide—CYP2C9—Sorafenib—thyroid cancer	0.0142	0.032	CbGbCtD
Nateglinide—CYP3A4—Vandetanib—thyroid cancer	0.0137	0.0309	CbGbCtD
Nateglinide—CYP2D6—Sorafenib—thyroid cancer	0.013	0.0293	CbGbCtD
Nateglinide—CYP3A4—Sorafenib—thyroid cancer	0.00828	0.0186	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—thyroid cancer	0.0079	0.0178	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—thyroid cancer	0.00502	0.0113	CbGbCtD
Nateglinide—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.00188	0.054	CcSEcCtD
Nateglinide—Hypoglycaemia—Vandetanib—thyroid cancer	0.00122	0.035	CcSEcCtD
Nateglinide—Influenza—Vandetanib—thyroid cancer	0.00103	0.0295	CcSEcCtD
Nateglinide—Bronchitis—Vandetanib—thyroid cancer	0.000991	0.0284	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.000957	0.0274	CcSEcCtD
Nateglinide—Hepatobiliary disease—Vandetanib—thyroid cancer	0.000869	0.0249	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—thyroid cancer	0.000792	1	CrCbGaD
Nateglinide—Erythema multiforme—Vandetanib—thyroid cancer	0.000779	0.0223	CcSEcCtD
Nateglinide—Malnutrition—Vandetanib—thyroid cancer	0.000718	0.0206	CcSEcCtD
Nateglinide—Tremor—Vandetanib—thyroid cancer	0.000672	0.0193	CcSEcCtD
Nateglinide—Cough—Vandetanib—thyroid cancer	0.000626	0.0179	CcSEcCtD
Nateglinide—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000607	0.0174	CcSEcCtD
Nateglinide—Jaundice—Sorafenib—thyroid cancer	0.000604	0.0173	CcSEcCtD
Nateglinide—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000586	0.0168	CcSEcCtD
Nateglinide—Erythema multiforme—Sorafenib—thyroid cancer	0.000526	0.0151	CcSEcCtD
Nateglinide—Dyspepsia—Vandetanib—thyroid cancer	0.000516	0.0148	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000506	0.0145	CcSEcCtD
Nateglinide—Fatigue—Vandetanib—thyroid cancer	0.000505	0.0145	CcSEcCtD
Nateglinide—Immune system disorder—Sorafenib—thyroid cancer	0.000502	0.0144	CcSEcCtD
Nateglinide—Malnutrition—Sorafenib—thyroid cancer	0.000484	0.0139	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000479	0.0137	CcSEcCtD
Nateglinide—Abdominal pain—Vandetanib—thyroid cancer	0.000463	0.0133	CcSEcCtD
Nateglinide—Arthropathy—Epirubicin—thyroid cancer	0.00045	0.0129	CcSEcCtD
Nateglinide—Cough—Sorafenib—thyroid cancer	0.000422	0.0121	CcSEcCtD
Nateglinide—Asthenia—Vandetanib—thyroid cancer	0.00042	0.012	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—thyroid cancer	0.000416	0.0119	CcSEcCtD
Nateglinide—Pruritus—Vandetanib—thyroid cancer	0.000414	0.0119	CcSEcCtD
Nateglinide—Diarrhoea—Vandetanib—thyroid cancer	0.000401	0.0115	CcSEcCtD
Nateglinide—Dizziness—Vandetanib—thyroid cancer	0.000387	0.0111	CcSEcCtD
Nateglinide—Vomiting—Vandetanib—thyroid cancer	0.000372	0.0107	CcSEcCtD
Nateglinide—Rash—Vandetanib—thyroid cancer	0.000369	0.0106	CcSEcCtD
Nateglinide—Dermatitis—Vandetanib—thyroid cancer	0.000369	0.0106	CcSEcCtD
Nateglinide—Nausea—Vandetanib—thyroid cancer	0.000348	0.00997	CcSEcCtD
Nateglinide—Dyspepsia—Sorafenib—thyroid cancer	0.000348	0.00996	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000341	0.00977	CcSEcCtD
Nateglinide—Fatigue—Sorafenib—thyroid cancer	0.000341	0.00976	CcSEcCtD
Nateglinide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000323	0.00926	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—thyroid cancer	0.000316	0.00906	CcSEcCtD
Nateglinide—Urticaria—Sorafenib—thyroid cancer	0.000314	0.00899	CcSEcCtD
Nateglinide—Abdominal pain—Sorafenib—thyroid cancer	0.000312	0.00895	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—thyroid cancer	0.000304	0.00872	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—thyroid cancer	0.000297	0.00851	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—thyroid cancer	0.000293	0.00838	CcSEcCtD
Nateglinide—Hypersensitivity—Sorafenib—thyroid cancer	0.000291	0.00834	CcSEcCtD
Nateglinide—Asthenia—Sorafenib—thyroid cancer	0.000283	0.00812	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000282	0.00807	CcSEcCtD
Nateglinide—Pruritus—Sorafenib—thyroid cancer	0.00028	0.00801	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—thyroid cancer	0.000275	0.00787	CcSEcCtD
Nateglinide—Diarrhoea—Sorafenib—thyroid cancer	0.00027	0.00774	CcSEcCtD
Nateglinide—Dizziness—Sorafenib—thyroid cancer	0.000261	0.00748	CcSEcCtD
Nateglinide—Influenza—Epirubicin—thyroid cancer	0.000257	0.00736	CcSEcCtD
Nateglinide—Vomiting—Sorafenib—thyroid cancer	0.000251	0.0072	CcSEcCtD
Nateglinide—Rash—Sorafenib—thyroid cancer	0.000249	0.00714	CcSEcCtD
Nateglinide—Dermatitis—Sorafenib—thyroid cancer	0.000249	0.00713	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—thyroid cancer	0.000247	0.00707	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000239	0.00684	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—thyroid cancer	0.000238	0.00681	CcSEcCtD
Nateglinide—Nausea—Sorafenib—thyroid cancer	0.000235	0.00672	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—thyroid cancer	0.000228	0.00655	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000224	0.00643	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—thyroid cancer	0.000223	0.00639	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000221	0.00633	CcSEcCtD
Nateglinide—Sweating—Epirubicin—thyroid cancer	0.000219	0.00629	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000217	0.0062	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000208	0.00595	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—thyroid cancer	0.000206	0.00592	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—thyroid cancer	0.000203	0.00582	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—thyroid cancer	0.000202	0.0058	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.0002	0.00574	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—thyroid cancer	0.000194	0.00557	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—thyroid cancer	0.000187	0.00537	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—thyroid cancer	0.000186	0.00532	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—thyroid cancer	0.00018	0.00515	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—thyroid cancer	0.000179	0.00513	CcSEcCtD
Nateglinide—Back pain—Epirubicin—thyroid cancer	0.000173	0.00496	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—thyroid cancer	0.000172	0.00492	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—thyroid cancer	0.000166	0.00474	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—thyroid cancer	0.00016	0.00459	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—thyroid cancer	0.000158	0.00453	CcSEcCtD
Nateglinide—Cough—Epirubicin—thyroid cancer	0.000156	0.00447	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—thyroid cancer	0.000146	0.00419	CcSEcCtD
Nateglinide—Cough—Doxorubicin—thyroid cancer	0.000144	0.00414	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000141	0.00404	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000131	0.00374	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—thyroid cancer	0.000129	0.00368	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000126	0.00361	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—thyroid cancer	0.000126	0.00361	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000119	0.00342	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—thyroid cancer	0.000119	0.00341	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000117	0.00334	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—thyroid cancer	0.000116	0.00334	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—thyroid cancer	0.000116	0.00332	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—thyroid cancer	0.000115	0.00331	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00011	0.00316	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—thyroid cancer	0.000108	0.00308	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—thyroid cancer	0.000107	0.00307	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—thyroid cancer	0.000107	0.00306	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—thyroid cancer	0.000105	0.003	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—thyroid cancer	0.000103	0.00296	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—thyroid cancer	9.99e-05	0.00286	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—thyroid cancer	9.95e-05	0.00285	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—thyroid cancer	9.69e-05	0.00278	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—thyroid cancer	9.66e-05	0.00277	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—thyroid cancer	9.56e-05	0.00274	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—thyroid cancer	9.28e-05	0.00266	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—thyroid cancer	9.24e-05	0.00265	CcSEcCtD
Nateglinide—Rash—Epirubicin—thyroid cancer	9.21e-05	0.00264	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—thyroid cancer	9.2e-05	0.00263	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—thyroid cancer	8.93e-05	0.00256	CcSEcCtD
Nateglinide—Nausea—Epirubicin—thyroid cancer	8.67e-05	0.00248	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—thyroid cancer	8.59e-05	0.00246	CcSEcCtD
Nateglinide—Rash—Doxorubicin—thyroid cancer	8.52e-05	0.00244	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—thyroid cancer	8.51e-05	0.00244	CcSEcCtD
Nateglinide—PPARG—Metabolism—MINPP1—thyroid cancer	8.31e-05	0.00205	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.25e-05	0.00203	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—CP—thyroid cancer	8.25e-05	0.00203	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—RXRA—thyroid cancer	8.17e-05	0.00201	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.12e-05	0.002	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—TRIM33—thyroid cancer	8.1e-05	0.002	CbGpPWpGaD
Nateglinide—Nausea—Doxorubicin—thyroid cancer	8.03e-05	0.0023	CcSEcCtD
Nateglinide—PTGS1—Biological oxidations—RXRA—thyroid cancer	7.92e-05	0.00195	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.91e-05	0.00195	CbGpPWpGaD
Nateglinide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.84e-05	0.00193	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	7.8e-05	0.00192	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	7.72e-05	0.0019	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—CP—thyroid cancer	7.66e-05	0.00189	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.66e-05	0.00189	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.53e-05	0.00186	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—HPGD—thyroid cancer	7.47e-05	0.00184	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	7.42e-05	0.00183	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	7.35e-05	0.00181	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—HPGD—thyroid cancer	7.24e-05	0.00179	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—HPGD—thyroid cancer	7.14e-05	0.00176	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MINPP1—thyroid cancer	7.14e-05	0.00176	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NDUFA13—thyroid cancer	7.06e-05	0.00174	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.86e-05	0.00169	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	6.73e-05	0.00166	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CHST14—thyroid cancer	6.64e-05	0.00164	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	6.63e-05	0.00163	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IFNA2—thyroid cancer	6.59e-05	0.00162	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—BRAF—thyroid cancer	6.59e-05	0.00162	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.55e-05	0.00162	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	6.53e-05	0.00161	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	6.53e-05	0.00161	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.42e-05	0.00158	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—BRAF—thyroid cancer	6.39e-05	0.00158	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.38e-05	0.00157	CbGpPWpGaD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	6.34e-05	0.00156	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.17e-05	0.00152	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NDUFA13—thyroid cancer	6.07e-05	0.0015	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MINPP1—thyroid cancer	6e-05	0.00148	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	5.92e-05	0.00146	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—RXRA—thyroid cancer	5.91e-05	0.00146	CbGpPWpGaD
Nateglinide—PPARG—SREBP signalling—AKT1—thyroid cancer	5.86e-05	0.00144	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—THRB—thyroid cancer	5.85e-05	0.00144	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MINPP1—thyroid cancer	5.82e-05	0.00143	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	5.81e-05	0.00143	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	5.81e-05	0.00143	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.76e-05	0.00142	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.73e-05	0.00141	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CHST14—thyroid cancer	5.71e-05	0.00141	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	5.68e-05	0.0014	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	5.68e-05	0.0014	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.59e-05	0.00138	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	5.56e-05	0.00137	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.51e-05	0.00136	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.41e-05	0.00133	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—HPGD—thyroid cancer	5.35e-05	0.00132	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CDK1—thyroid cancer	5.24e-05	0.00129	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.19e-05	0.00128	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.17e-05	0.00127	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	5.17e-05	0.00127	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NDUFA13—thyroid cancer	5.11e-05	0.00126	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NDUFA13—thyroid cancer	4.95e-05	0.00122	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IFNA2—thyroid cancer	4.91e-05	0.00121	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.89e-05	0.0012	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—RXRA—thyroid cancer	4.86e-05	0.0012	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.81e-05	0.00119	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CHST14—thyroid cancer	4.8e-05	0.00118	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CHST14—thyroid cancer	4.65e-05	0.00115	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—HPGD—thyroid cancer	4.6e-05	0.00113	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.43e-05	0.00109	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	4.35e-05	0.00107	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.34e-05	0.00107	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MINPP1—thyroid cancer	4.34e-05	0.00107	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	4.32e-05	0.00107	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	4.32e-05	0.00106	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TPR—thyroid cancer	4.29e-05	0.00106	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.25e-05	0.00105	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	4.22e-05	0.00104	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—RXRA—thyroid cancer	4.2e-05	0.00104	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.16e-05	0.00103	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TPR—thyroid cancer	4.16e-05	0.00103	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.11e-05	0.00101	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TPR—thyroid cancer	4.1e-05	0.00101	CbGpPWpGaD
Nateglinide—PPARG—neck—thyroid cancer	4.1e-05	0.0883	CbGeAlD
Nateglinide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	4.09e-05	0.00101	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PRKAR1A—thyroid cancer	4.03e-05	0.000994	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—TPR—thyroid cancer	3.95e-05	0.000975	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HPGD—thyroid cancer	3.87e-05	0.000954	CbGpPWpGaD
Nateglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	3.78e-05	0.000932	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HPGD—thyroid cancer	3.75e-05	0.000924	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MINPP1—thyroid cancer	3.74e-05	0.000921	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.73e-05	0.00092	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MEN1—thyroid cancer	3.72e-05	0.000916	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NDUFA13—thyroid cancer	3.69e-05	0.00091	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.57e-05	0.000881	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CHST14—thyroid cancer	3.47e-05	0.000855	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PRKAR1A—thyroid cancer	3.36e-05	0.000827	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—thyroid cancer	3.24e-05	0.000798	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SLC5A5—thyroid cancer	3.21e-05	0.000792	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NDUFA13—thyroid cancer	3.18e-05	0.000783	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	3.11e-05	0.000768	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.09e-05	0.000761	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TPR—thyroid cancer	3.08e-05	0.000758	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SLC5A5—thyroid cancer	3.07e-05	0.000757	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.06e-05	0.000754	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.04e-05	0.00075	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—HRAS—thyroid cancer	3.03e-05	0.000747	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PRKAR1A—thyroid cancer	3.03e-05	0.000746	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CHST14—thyroid cancer	2.99e-05	0.000737	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	2.95e-05	0.000728	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	2.95e-05	0.000728	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—thyroid cancer	2.95e-05	0.000727	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—HRAS—thyroid cancer	2.94e-05	0.000724	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.91e-05	0.000716	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HPGD—thyroid cancer	2.8e-05	0.000689	CbGpPWpGaD
Nateglinide—KCNJ11—thyroid gland—thyroid cancer	2.77e-05	0.0598	CbGeAlD
Nateglinide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.75e-05	0.000677	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—RXRA—thyroid cancer	2.7e-05	0.000665	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TPR—thyroid cancer	2.64e-05	0.000651	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.62e-05	0.000647	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—RXRA—thyroid cancer	2.62e-05	0.000645	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.6e-05	0.000641	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	2.6e-05	0.000641	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—RXRA—thyroid cancer	2.58e-05	0.000636	CbGpPWpGaD
Nateglinide—ABCC8—thyroid gland—thyroid cancer	2.55e-05	0.055	CbGeAlD
Nateglinide—SLC15A2—saliva-secreting gland—thyroid cancer	2.5e-05	0.0539	CbGeAlD
Nateglinide—PPARG—Gene Expression—RXRA—thyroid cancer	2.49e-05	0.000613	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CHST14—thyroid cancer	2.47e-05	0.000608	CbGpPWpGaD
Nateglinide—KCNJ11—head—thyroid cancer	2.46e-05	0.053	CbGeAlD
Nateglinide—SLC16A1—Hemostasis—NRAS—thyroid cancer	2.46e-05	0.000606	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CHST14—thyroid cancer	2.45e-05	0.000603	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HPGD—thyroid cancer	2.41e-05	0.000594	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.36e-05	0.000581	CbGpPWpGaD
Nateglinide—SLC16A1—thyroid gland—thyroid cancer	2.32e-05	0.0501	CbGeAlD
Nateglinide—PPARG—Metabolism—SLC5A5—thyroid cancer	2.3e-05	0.000567	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.3e-05	0.000566	CbGpPWpGaD
Nateglinide—ABCC8—head—thyroid cancer	2.27e-05	0.0488	CbGeAlD
Nateglinide—ALB—Hemostasis—IFNA2—thyroid cancer	2.22e-05	0.000548	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TPR—thyroid cancer	2.22e-05	0.000548	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.21e-05	0.000545	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.19e-05	0.000539	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.16e-05	0.000532	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TPR—thyroid cancer	2.15e-05	0.000531	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PRKAR1A—thyroid cancer	2.12e-05	0.000522	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—KRAS—thyroid cancer	2.12e-05	0.000522	CbGpPWpGaD
Nateglinide—SLC16A1—head—thyroid cancer	2.06e-05	0.0444	CbGeAlD
Nateglinide—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.02e-05	0.000497	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HPGD—thyroid cancer	1.99e-05	0.00049	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC5A5—thyroid cancer	1.98e-05	0.000488	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HPGD—thyroid cancer	1.97e-05	0.000486	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.95e-05	0.000482	CbGpPWpGaD
Nateglinide—PPARG—thyroid gland—thyroid cancer	1.95e-05	0.042	CbGeAlD
Nateglinide—PPARG—Metabolism—RXRA—thyroid cancer	1.93e-05	0.000477	CbGpPWpGaD
Nateglinide—SLC15A2—trachea—thyroid cancer	1.93e-05	0.0416	CbGeAlD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.92e-05	0.000473	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	0.000464	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—thyroid cancer	1.88e-05	0.000464	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NRAS—thyroid cancer	1.88e-05	0.000463	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.86e-05	0.000458	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.85e-05	0.000457	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NRAS—thyroid cancer	1.83e-05	0.000452	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—thyroid cancer	1.8e-05	0.000443	CbGpPWpGaD
Nateglinide—ABCC4—thyroid gland—thyroid cancer	1.77e-05	0.0381	CbGeAlD
Nateglinide—PPARG—head—thyroid cancer	1.73e-05	0.0373	CbGeAlD
Nateglinide—KCNJ11—lymph node—thyroid cancer	1.72e-05	0.0371	CbGeAlD
Nateglinide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.72e-05	0.000423	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PPARG—thyroid cancer	1.7e-05	0.00042	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.66e-05	0.00041	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—RXRA—thyroid cancer	1.66e-05	0.00041	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PPARG—thyroid cancer	1.65e-05	0.000407	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PPARG—thyroid cancer	1.63e-05	0.000401	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—thyroid cancer	1.62e-05	0.000399	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.62e-05	0.000398	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CHST14—thyroid cancer	1.61e-05	0.000398	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC5A5—thyroid cancer	1.61e-05	0.000397	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TPR—thyroid cancer	1.61e-05	0.000396	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.6e-05	0.000394	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—thyroid cancer	1.59e-05	0.000391	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.58e-05	0.00039	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—thyroid cancer	1.58e-05	0.000389	CbGpPWpGaD
Nateglinide—ABCC4—head—thyroid cancer	1.57e-05	0.0338	CbGeAlD
Nateglinide—SLC15A2—thyroid gland—thyroid cancer	1.53e-05	0.0329	CbGeAlD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.51e-05	0.000372	CbGpPWpGaD
Nateglinide—SLC16A1—lymph node—thyroid cancer	1.44e-05	0.0311	CbGeAlD
Nateglinide—ABCC4—Hemostasis—TP53—thyroid cancer	1.4e-05	0.000346	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—RXRA—thyroid cancer	1.4e-05	0.000345	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TPR—thyroid cancer	1.38e-05	0.000341	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—thyroid cancer	1.37e-05	0.000339	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PRKAR1A—thyroid cancer	1.36e-05	0.000335	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—RXRA—thyroid cancer	1.35e-05	0.000334	CbGpPWpGaD
Nateglinide—SLC15A2—head—thyroid cancer	1.35e-05	0.0292	CbGeAlD
Nateglinide—ABCC4—Hemostasis—HRAS—thyroid cancer	1.34e-05	0.000331	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—thyroid cancer	1.34e-05	0.00033	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.32e-05	0.000325	CbGpPWpGaD
Nateglinide—PTGS1—trachea—thyroid cancer	1.32e-05	0.0284	CbGeAlD
Nateglinide—CYP3A4—Metabolism—HPGD—thyroid cancer	1.3e-05	0.000321	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—thyroid cancer	1.3e-05	0.00032	CbGpPWpGaD
Nateglinide—ORM1—lymph node—thyroid cancer	1.3e-05	0.0279	CbGeAlD
Nateglinide—SLC16A1—Metabolism—PTGS2—thyroid cancer	1.28e-05	0.000316	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.23e-05	0.000304	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—thyroid cancer	1.21e-05	0.000299	CbGpPWpGaD
Nateglinide—PPARG—lymph node—thyroid cancer	1.21e-05	0.0261	CbGeAlD
Nateglinide—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000296	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—thyroid cancer	1.18e-05	0.000292	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000288	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TPR—thyroid cancer	1.14e-05	0.000282	CbGpPWpGaD
Nateglinide—ALB—lymph node—thyroid cancer	1.14e-05	0.0245	CbGeAlD
Nateglinide—KCNJ11—Metabolism—PTEN—thyroid cancer	1.13e-05	0.000279	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TPR—thyroid cancer	1.13e-05	0.000279	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.12e-05	0.000277	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—thyroid cancer	1.12e-05	0.000275	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.11e-05	0.000275	CbGpPWpGaD
Nateglinide—ABCC4—lymph node—thyroid cancer	1.1e-05	0.0237	CbGeAlD
Nateglinide—UGT1A9—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000259	CbGpPWpGaD
Nateglinide—PTGS1—thyroid gland—thyroid cancer	1.04e-05	0.0225	CbGeAlD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.04e-05	0.000256	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC5A5—thyroid cancer	1.04e-05	0.000255	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000249	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.01e-05	0.000249	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.7e-06	0.000239	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—thyroid cancer	9.61e-06	0.000237	CbGpPWpGaD
Nateglinide—SLC15A2—lymph node—thyroid cancer	9.48e-06	0.0204	CbGeAlD
Nateglinide—PTGS1—head—thyroid cancer	9.25e-06	0.0199	CbGeAlD
Nateglinide—CYP3A7—Metabolism—PPARG—thyroid cancer	8.83e-06	0.000218	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RXRA—thyroid cancer	8.7e-06	0.000214	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—thyroid cancer	8.55e-06	0.000211	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.55e-06	0.000211	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.48e-06	0.000209	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.46e-06	0.000209	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—thyroid cancer	8.38e-06	0.000206	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—thyroid cancer	8.29e-06	0.000204	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—thyroid cancer	8.26e-06	0.000203	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.94e-06	0.000196	CbGpPWpGaD
Nateglinide—CYP2D6—head—thyroid cancer	7.6e-06	0.0164	CbGeAlD
Nateglinide—CYP3A4—Metabolism—TPR—thyroid cancer	7.47e-06	0.000184	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.35e-06	0.000181	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—thyroid cancer	7.2e-06	0.000177	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RXRA—thyroid cancer	7.18e-06	0.000177	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—thyroid cancer	7.14e-06	0.000176	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RXRA—thyroid cancer	7.12e-06	0.000176	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—thyroid cancer	6.94e-06	0.000171	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.93e-06	0.000171	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—thyroid cancer	6.74e-06	0.000166	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—thyroid cancer	6.73e-06	0.000166	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—thyroid cancer	6.53e-06	0.000161	CbGpPWpGaD
Nateglinide—PTGS1—lymph node—thyroid cancer	6.47e-06	0.014	CbGeAlD
Nateglinide—SLC16A1—Metabolism—AKT1—thyroid cancer	6.44e-06	0.000159	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—thyroid cancer	6.38e-06	0.000157	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—thyroid cancer	6.34e-06	0.000156	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—thyroid cancer	6.21e-06	0.000153	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—thyroid cancer	6.07e-06	0.00015	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—thyroid cancer	6.05e-06	0.000149	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—thyroid cancer	5.87e-06	0.000145	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.59e-06	0.000138	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—thyroid cancer	5.49e-06	0.000135	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—thyroid cancer	5.36e-06	0.000132	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—thyroid cancer	5.02e-06	0.000124	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—thyroid cancer	4.83e-06	0.000119	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RXRA—thyroid cancer	4.7e-06	0.000116	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—thyroid cancer	4.54e-06	0.000112	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—thyroid cancer	4.5e-06	0.000111	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—thyroid cancer	4.38e-06	0.000108	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—thyroid cancer	4.32e-06	0.000107	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—thyroid cancer	4.15e-06	0.000102	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—thyroid cancer	3.77e-06	9.29e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.57e-06	8.8e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.54e-06	8.72e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—thyroid cancer	3.49e-06	8.6e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—thyroid cancer	3.38e-06	8.34e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—thyroid cancer	3.11e-06	7.67e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—thyroid cancer	3.09e-06	7.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—thyroid cancer	2.97e-06	7.31e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—thyroid cancer	2.52e-06	6.22e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.33e-06	5.75e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—thyroid cancer	2.17e-06	5.35e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—thyroid cancer	2.03e-06	5.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—thyroid cancer	1.79e-06	4.42e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—thyroid cancer	1.78e-06	4.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—thyroid cancer	1.17e-06	2.89e-05	CbGpPWpGaD
